Company Overview
Research and development of non-invasive diagnostic tests for early detection of cancer.
Website | www.bard1.com |
---|---|
Head Office | Notting Hill VIC |
Registry | Computershare Investor Services |
CEO | Leearne Hinch |
Chair Person | Geoffrey Cumming |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Services |
Sector | Health Care |
Market Cap | $94 m |
---|---|
Shares on Issue | 92 m |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Mrs Pauline Anne Collinson
Company Secretary 07/11/2001
Mrs Collinson has worked for the Company for 23 years and has held the position of Company Secretary for 14 years. She is also the Company Secretary of Tanami Gold NL (ASX:TAM).
Female
Professor Allan Cripps
Non-Executive Director 23/01/2020
Professor Cripps had near 20 years experience in the health and pharmaceutical industries before becoming a full-time academic focusing his research on mucosal immunology, respiratory tract infections, vaccine development and diagnostics. Professor Cripps is a academic, clinical scientist and health services leader, having made significant contributions in immunology, diagnostics and health services delivery. From 2005 to 2016, Professor Cripps was the Pro Vice Chancellor (Health) at Griffith University and is currently a research professor at Griffith University, led the Mucosal Immunology Research Group within the Menzies Health Institute Queensland. He has published over 300 peer reviewed scientific papers, presented at international scientific conferences, and is co-inventor on several international patents in the fields of diagnostics and vaccine protein antigens. Currently Professor Cripps is Independent Chair of the Children's Health Research Alliance Board. He was previously Non-Executive Director of Research Australia (2005 - 2012) and the Gold Coast Hospital and Health Services Board (2011 - 2017). Professor Cripps is a member of the Risk Committees.
AO, PhD, BSc (Hons), FAHSM, FASM, FAIMS, FIBMS, FC Professor Male
Mr Philip (Phil) John Powell
Non-Executive Director 17/06/2019
Mr Powell has experience in investment banking, specialising in capital raisings, initial public offerings (IPOs), mergers and acquisitions and other corporate finance assignments across a range of sectors including pharma, utilities, IT, financial services, food and agriculture. He spent 10 years in senior financial roles at OAMPS Ltd and 10 years in audit with Arthur Andersen & Co in Melbourne, Sydney and Los Angeles. He is also a Chairman of the Risk Committee.
BCom (Hons), ACA, FINSIA,MAICD,F.Fin Chartered Accountant Male
Mr Geoffrey A. Cumming
Non-Executive Chairman,Non-Executive Director 28/07/2020
--
BA (Hons), MSc (LSE) Male
Mr Robert (Max) Maxwell Johnston
Non-Executive Director 17/06/2019
Mr Johnston held the position of President and Chief Executive Officer of Johnson & Johnson Pacific, a division of the medical, pharmaceutical and consumer healthcare company for 11 years. Previously his career also included senior roles with Diageo and Unilever in Australia, Africa and Europe. Mr Johnston has also held several industry roles as a past President of ACCORD Australasia Limited, a former Vice Chairman of the Australian Food and Grocery Council and a former member of the board of the Australian Skills Management Institute (ASMI). Mr Johnston has had overseas experience during his career in businesses in both Western and Central Eastern Europe and Africa as well as the Asia-Pacific region. Mr Johnston is currently Non-Executive Director of ProLife Foods NZ.
FCDA, MAICD Male
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | HSBC Custody Nominees (Australia) Limited | 210,205,341 | 8.78 |
2. | The Trust Company Australia Limited <Mof A/C> | 204,000,000 | 8.52 |
3. | Moggs Creek Pty Ltd <Moggs Creek Super Fund A/C> | 130,790,000 | 5.46 |
4. | Dr Irmgard Irminger-Finger | 123,600,000 | 5.16 |
5. | J P Morgan Nominees Australia Pty Limited | 44,247,405 | 1.85 |
6. | Citicorp Nominees Pty Limited | 42,749,162 | 1.79 |
7. | Traoj Pty Ltd <Traoj A/C> | 36,087,995 | 1.51 |
8. | David Neate | 33,157,719 | 1.38 |
9. | BNP Paribas Nominees Pty Ltd <IB Au Noms Retailclient Drp> | 32,909,435 | 1.37 |
10. | Tony Walker | 30,867,552 | 1.29 |
11. | Mr John Andrew Rodgers <John Rodgers Family A/C> | 29,924,216 | 1.25 |
12. | Supergun Pty Ltd <Bricklanding Super Fund A/C> | 23,294,046 | 0.97 |
13. | Ajava Holdings Pty Ltd | 23,000,000 | 0.96 |
14. | Worldwise Enterprises Pty Ltd | 16,705,954 | 0.70 |
15. | Nathan Ryan Wagner | 16,558,112 | 0.69 |
16. | Barrie Ernest Laws & Merrilyn Frances Laws <B&M Laws Fund A/C> | 15,600,000 | 0.65 |
17. | Lynne Marie Wilks | 15,500,000 | 0.65 |
18. | Ifm Pty Limited <Ifm Super Fund A/C> | 15,166,666 | 0.63 |
19. | Russell Kay Hancock | 15,000,000 | 0.63 |
20. | Pelagyia Pty Ltd <Caprice Super Fund A/C> | 13,840,000 | 0.58 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
24/08/2021 | Philip (Phil) Powell | 19,354 | $29,998 | Buy | Participation in share purchase plan. |
24/08/2021 | Geoffrey Cumming | 19,354 | $29,998 | Buy | Participation in share purchase plan. |
24/08/2021 | Robert (Max) Johnston | 19,354 | $29,998 | Buy | Participation in share purchase plan. As per announcement on 27/08/2021 |
04/12/2020 | Geoffrey Cumming | 9,333 | $7,066 | Buy | On-market trade. Avg price |
02/12/2020 | Robert (Max) Johnston | 30,000 | $20,385 | Buy | On-market trade. Avg price. |
02/12/2020 | Philip (Phil) Powell | 70,000 | $48,762 | Buy | On-market trade. Avg price |